Patent · US Active

Tn-MUC1 chimeric antigen receptor (CAR) T cell therapy

US11090336B2 · kind B2 · utility

2Cited by

49References

10Claims

0Family size

Assignee

The Trustees of the University of Pennsylvania · US

Inventors

Avery D. Posey · Philadelphia, US
Carl H. June · Yeadon, US

Key dates

Filing date	Mar 26, 2020
Grant date	Aug 17, 2021
Priority date	—
Expiry date	Mar 26, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/33
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Various TnMUC1-specific chimeric antigen receptors (CARs), nucleic acids encoding the same, and methods of using the same, are provided. Compositions and methods comprising a TnMUC1-specific CAR for treating MUC1-associated cancer in a subject in need thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.